$2.51
+0.02 (+0.80%)
Open$2.49
Previous Close$2.49
Day High$2.53
Day Low$2.44
52W High$5.59
52W Low$2.85
Volume—
Avg Volume34.4K
Market Cap298.85M
P/E Ratio—
EPS$-0.55
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,446.2% upside
Current
$2.51
$2.51
Target
$38.81
$38.81
$30.55
$38.81 avg
$50.01
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 860.60M | 726.18M | 117.29M |
| Net Income | -73,522,531 | -55,835,185 | 15.94M |
| Profit Margin | -8.5% | -8.1% | 13.6% |
| EBITDA | 15.03M | 12.05M | 20.19M |
| Free Cash Flow | — | — | 10.06M |
| Rev Growth | +18.5% | +18.5% | +17.8% |
| Debt/Equity | 1.25 | 1.25 | 1.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |